A drug that blocks a male hormone receptor prolonged life by nearly a year compared with the placebo in men with nonmetastatic, castration-resistant prostate cancer, according to the final analysis of the results of an international, multi-center Phase 3 clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators.
A Conversation with Dr. Ravi Sharaf
June 3, 2020
We hope you enjoy the following conversation with EIPM Member Dr. Ravi Sharaf.
Ravi Sharaf, M.D., M.S., is a Member of the Englander Institute for Precision Medicine, an Associate Professor of Medicine (Gastroenterology) with a secondary appointment as Associate Professor of Population Health Sciences (Epidemiology).
A Conversation with Princesca Dorsaint
May 7, 2020
Princesca Dorsaint is a Bioinformatics Analyst at the Englander Institute for Precision Medicine. She was born and raised in New York, and received her undergraduate degree in Health Science from The University of Hartford, and then later pursued a second undergraduate degree in Biomedical Informatics from The New York City College of Technology. She has been at Weill Cornell Medicine for a year and a half.
We hope you enjoy learning more about Princesca, her career goals, and how she’s staying healthy during the global pandemic.
Treating Cancer Patients Amid the Pandemic
April 24, 2020
A diagnosis of cancer is one of the most frightening things a patient could ever receive . Despite great advances made in treatment, early detection, and prevention, patients will often feel vulnerable and lost in a maze of the unknown. And now, in the face of the ongoing coronavirus pandemic, every one of us — the healthy and those with health ailments — also feels vulnerable.
Macaulay Students to Assist With COVID-19 Effort
April 10, 2020
Interns in the Englander Institute for Precision Medicine at Weill Cornell Medicine/RLab internship program will work on a tool to identify areas in the US where COVID-19 symptoms are emerging.
Macaulay Honors College today announced a plan for student interns in the college’s RLab program to be redeployed to assist in a national COVID-19 monitoring effort.
EIPM Launches Weekly News Roundup!
April 10, 2020
During normal times it can be difficult to find reliable and accurate news about health, medicine and science. But during a global pandemic, when information can directly affect our lives and our work, this challenge takes on far greater significance.
April 2020 EIPM Director’s Memo
April 1, 2020
April 2020
Dear Colleagues,
We are living through extraordinary times, and I thank everyone for taking the steps necessary to stay healthy and care for family, friends and loved ones.
New York Times: How Are You Feeling? Surveys Aim to Detect Covid-19 Hot Spots Early
April 1, 2020
Scientists have persuaded Britons and Israelis to fill out questionnaires about their health, to get ahead of the coronavirus by getting resources to the right place. The U.S. is next.
EIPM Joins Very Rare Cancer Research Initiative
June 26, 2019
NEW YORK – When a patient turned up at the Weill Cornell Medical Center a few years ago with a typically benign kidney tumor type, it did not initially set off alarm bells. The tumor didn’t seem all that threatening, and the patient was an adult, albeit somewhat younger than individuals who usually come in with that kind of tumor.
A Conversation with Dr. M. Laura Martin
May 29, 2019
M. Laura Martin, Ph.D. was recently promoted to the Core Leadership Team at the Englander Institute for Precision Medicine (EIPM) as Ex Vivo Models Director. In this new capacity she will lead efforts in the utilization of patient derived models of cancer, studying the functional impact of genetic and epigenetic alterations in preclinical models, and investigating the potential to translate these findings to clinical relevance.